Syncom Formulations (India) Ltd (SYNCOMF)
₹15.38▲2.67%
Performance
Day's Low
Day's High
₹15.02₹15.6452 Week's Low
52 Week's High
₹7.15₹18.65
| Returns % | |
| 1 Month Return | + 16.21 % |
| 3 Month Return | + 6.62 % |
| 1 Year Return | + 103.81 % |
| Market Stats | |
| Previous Close | ₹14.98 |
| Open | ₹15.02 |
| Volume | 56.26L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,408.12Cr |
Key Statistics
| P/E Ratio | 44.06 |
| PEG Ratio | 489.54 |
| Market Cap | ₹1,408.12 Cr |
| P/B Ratio | 2.17 |
| EPS | 0.12 |
Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
 | NA | ₹1,408.12 Cr | 349.88% | 0.63 | ₹20 Cr | ₹224 Cr |
| NA | ₹17.18 Cr | -6.84% | 0.50 | -₹3 Cr | ₹45 Cr |
| NA | ₹164.28 Cr | 90.19% | 0.58 | NA | NA |
 | NA | ₹1,131.02 Cr | 120.9% | 0.54 | ₹27 Cr | ₹550 Cr |
| NA | ₹14.76 Cr | 80.9% | 0.69 | NA | NA |
Company Information
Share Price: ₹15.38 per share as on 24 Jul, 2024 04:01 PM
Market Capitalisation: ₹1,408.12Cr as of today
Revenue: ₹74.57Cr as on March 2024 (Q1 24)
Net Profit: ₹7.40Cr as on March 2024 (Q1 24)
Listing date: 18 Nov, 2022
Chairperson Name: Kedarmal Bankda
| Organisation | Syncom Formulations (India) Ltd |
| Headquarters | Indore |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Syncom Formulations (India) Ltd
Individual Investors Own 49% of Syncom Formulations (India) Ltd - 13 Jul, 2024
Individual investors own the majority stake in Syncom Formulations (India) Ltd with 49% ownership, while insiders hold a reasonable proportion. The top six shareholders own 51% of the company, and insider ownership signals positive leadership thinking. Insiders own ₹5.7b worth of shares in the ₹14b company.
Insights on Syncom Formulations (India) Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 month, SYNCOMF stock has moved up by 16.2%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 61.71 Cr → 77.67 Cr (in ₹), with an average increase of 7.3% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.00% to 0.08% in Mar 2024 quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, SYNCOMF has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, 4.4 Cr → 7.4 Cr (in ₹), with an average increase of 14.9% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 50.57% of holdings in Mar 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.7% return, outperforming this stock by 40.4%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 49.43% to 49.35% in Mar 2024 quarter
Company Financials
| Q'1 24 | Q/Q Change | |
|---|---|---|
Revenue | ₹74.57Cr | ↑14.48% |
Net Income | ₹7.40Cr | ↑5.71% |
Net Profit Margin | 9.92% | ↓7.72% |
| 2023 | Y/Y Change | |
|---|---|---|
Revenue | ₹224.25Cr | ↑2.09% |
Net Income | ₹20.07Cr | ↑1.41% |
Net Profit Margin | 8.95% | ↓0.67% |
| 2023 | Y/Y Change | |
|---|---|---|
Total Assets | ₹377.62Cr | ↑22.27% |
Total Liabilities | ₹121.61Cr | ↑40.43% |
| 2023 | Y/Y Change | |
|---|---|---|
Operating Cash Flow | ₹10.50Cr | ↓35.70% |
Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 50.57% | 0.00 | |
| Foreign Institutions | 0.08% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 49.35% | 0.00 | |
| Others | 0% | 0.00 |
Key Indicators
Syncom Formulations (India) Ltd Valuation
Syncom Formulations (India) Ltd in the last 5 years
Lowest (3.98x)
March 12, 2020
Today (44.06x)
July 23, 2024
Industry (56.07x)
July 23, 2024
Highest (81.74x)
January 18, 2022
Earnings and Dividends
Syncom Formulations (India) Ltd Earnings Results
Syncom Formulations (India) Ltd’s net profit fell -12.63% since last year same period to ₹7.40Cr in the Q4 2023-2024. On a quarterly growth basis, Syncom Formulations (India) Ltd has generated 5.71% jump in its net profits since last 3-months.
Read More about Earnings ResultsSyncom Formulations (India) Ltd Dividends August,2022
In the quarter ending June 2022, Syncom Formulations (India) Ltd has declared dividend of ₹0.03 - translating a dividend yield of 0.20%.
Read More about Dividends
Technicals Summary
Bearish
Neutral
Bullish
Syncom Formulations (India) Ltd is currently in a Bullish trading position according to technical analysis indicators.
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Syncom Formulations (India) Ltd shares.
Syncom Formulations (India) Ltd (SYNCOMF) share price today is ₹15.38
Syncom Formulations (India) Ltd is listed on NSE
Syncom Formulations (India) Ltd is listed on BSE
- Today’s highest price of Syncom Formulations (India) Ltd is ₹15.64.
- Today’s lowest price of Syncom Formulations (India) Ltd is ₹15.02.
PE Ratio of Syncom Formulations (India) Ltd is 44.06
PE ratio = Syncom Formulations (India) Ltd Market price per share / Syncom Formulations (India) Ltd Earnings per share
Today’s traded volume of Syncom Formulations (India) Ltd(SYNCOMF) is 56.26L.
Today’s market capitalisation of Syncom Formulations (India) Ltd(SYNCOMF) is ₹1408.12Cr.
| Syncom Formulations (India) Ltd(SYNCOMF | Price |
|---|---|
52 Week High | ₹18.65 |
52 Week Low | ₹7.15 |
Syncom Formulations (India) Ltd(SYNCOMF) share price is ₹15.38. It is down -17.53% from its 52 Week High price of ₹18.65
Syncom Formulations (India) Ltd(SYNCOMF) share price is ₹15.38. It is up 115.10% from its 52 Week Low price of ₹7.15
| Syncom Formulations (India) Ltd(SYNCOMF | Returns |
|---|---|
1 Day Returns | 0.4% |
1 Month Returns | 16.21% |
3 Month Returns | 6.62% |
1 Year Returns | 103.81% |